| Carter Page Fenton Jr, DO | |
|
15740 S Outer 40 Rd, Chesterfield, MO 63017-2004 | |
| (636) 735-4205 | |
| Not Available |
| Full Name | Carter Page Fenton Jr |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 15740 S Outer 40 Rd, Chesterfield, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922199546 | NPI | - | NPPES |
| 190050155 | Other | CPIN ST ANTHONYS | |
| 245164207 | Medicaid | MO | |
| 930110488 | Other | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 20111052 (Missouri) | Primary |
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245277631 PECOS PAC ID: 7416865845 Enrollment ID: O20031104000060 |
News Archive
Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.
Older married adults whose spouse has dementia are at significantly higher risk for developing dementia themselves, compared to similar older married adults whose spouse never develops dementia. This is the key finding of a study published today in the Journal of the American Geriatrics Society.
Traveling restraints and shelter-in-place orders that grounded planes and emptied streets during the first wave of the COVID-19 pandemic brought greenhouse gas emissions down and air quality up.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.
› Verified 8 days ago
| Entity Name | Mercy Clinic Springfield Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972771657 PECOS PAC ID: 7416865845 Enrollment ID: O20031218000354 |
News Archive
Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.
Older married adults whose spouse has dementia are at significantly higher risk for developing dementia themselves, compared to similar older married adults whose spouse never develops dementia. This is the key finding of a study published today in the Journal of the American Geriatrics Society.
Traveling restraints and shelter-in-place orders that grounded planes and emptied streets during the first wave of the COVID-19 pandemic brought greenhouse gas emissions down and air quality up.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.
› Verified 8 days ago
| Entity Name | Mercy Clinic East Communities |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851335228 PECOS PAC ID: 7214827922 Enrollment ID: O20070521000006 |
News Archive
Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.
Older married adults whose spouse has dementia are at significantly higher risk for developing dementia themselves, compared to similar older married adults whose spouse never develops dementia. This is the key finding of a study published today in the Journal of the American Geriatrics Society.
Traveling restraints and shelter-in-place orders that grounded planes and emptied streets during the first wave of the COVID-19 pandemic brought greenhouse gas emissions down and air quality up.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.
› Verified 8 days ago
| Entity Name | Mercy Hospital Lincoln |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962808733 PECOS PAC ID: 5193040020 Enrollment ID: O20150623002541 |
News Archive
Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.
Older married adults whose spouse has dementia are at significantly higher risk for developing dementia themselves, compared to similar older married adults whose spouse never develops dementia. This is the key finding of a study published today in the Journal of the American Geriatrics Society.
Traveling restraints and shelter-in-place orders that grounded planes and emptied streets during the first wave of the COVID-19 pandemic brought greenhouse gas emissions down and air quality up.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.
› Verified 8 days ago
| Entity Name | Mercy Aco Clinical Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063965093 PECOS PAC ID: 6901188572 Enrollment ID: O20170117001888 |
News Archive
Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.
Older married adults whose spouse has dementia are at significantly higher risk for developing dementia themselves, compared to similar older married adults whose spouse never develops dementia. This is the key finding of a study published today in the Journal of the American Geriatrics Society.
Traveling restraints and shelter-in-place orders that grounded planes and emptied streets during the first wave of the COVID-19 pandemic brought greenhouse gas emissions down and air quality up.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.
› Verified 8 days ago
| Entity Name | Mercy Southern Missouri Ambulatory Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871094052 PECOS PAC ID: 5193089621 Enrollment ID: O20180508002317 |
News Archive
Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.
Older married adults whose spouse has dementia are at significantly higher risk for developing dementia themselves, compared to similar older married adults whose spouse never develops dementia. This is the key finding of a study published today in the Journal of the American Geriatrics Society.
Traveling restraints and shelter-in-place orders that grounded planes and emptied streets during the first wave of the COVID-19 pandemic brought greenhouse gas emissions down and air quality up.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carter Page Fenton Jr, DO 15740 S Outer 40 Rd, Chesterfield, MO 63017-2004 Ph: (636) 735-4205 | Carter Page Fenton Jr, DO 15740 S Outer 40 Rd, Chesterfield, MO 63017-2004 Ph: (636) 735-4205 |
News Archive
Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the second quarter of 2013.
Older married adults whose spouse has dementia are at significantly higher risk for developing dementia themselves, compared to similar older married adults whose spouse never develops dementia. This is the key finding of a study published today in the Journal of the American Geriatrics Society.
Traveling restraints and shelter-in-place orders that grounded planes and emptied streets during the first wave of the COVID-19 pandemic brought greenhouse gas emissions down and air quality up.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out. Though treatable, some methods can be ineffective or cause unwanted side effects.
› Verified 8 days ago
Dr. Michael J Meinzen, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6990 Fax: 314-205-6073 | |
Dr. Michael J Klevens, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6990 Fax: 314-205-6073 | |
Dr. Gary P Lessmann, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 201 W Manor Dr, Chesterfield, MO 63017 Phone: 314-576-7357 | |
Dr. Abdul Moheet, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6990 Fax: 314-205-6073 | |
Milton Sallis, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 378 Dinsmoor Dr, Chesterfield, Chesterfield, MO 63017 Phone: 314-583-9142 | |
Dr. David M Crane, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 17300 N Outer 40 Rd Ste 201, Chesterfield, MO 63005 Phone: 636-778-2900 Fax: 636-778-2828 | |
David S Lickerman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Road, Chesterfield, MO 63017 Phone: 314-205-6990 |